Acuitas offers tailored, perceptive and astute commercial insight enriched with top International
Key ​Opinion Leader feedback for the pharma, biotech and investment communities.
​​Providing a unique perspective to support those vital decisions.

​​What we offer

The Healthcare environment is getting more and more complex, and making the right strategic and investment decisions is becoming more and more challenging. Based on years of experience, Acuitas offers tailored, perceptive and astute commercial insight to the pharma, biotech and investment communities.

Extra resource or a fresh perspective
If you need an enriched snapshot of a therapy area, with a focus on your specific informational needs, we can deploy our model flexibly to support your requirements.

Examples of situations where we can help include:
• Royalty/Hedge funds evaluating potential investments in a company/asset
• Pharma/Biotech companies evaluating potential acquisitions/partnerships
• Service companies needing insight to develop relevant solutions & differentiate vs competition
• Pharma/Biotech companies wanting independent opinion on current/pipeline products ​

​
​Our Approach

Our tried and tested model can be adapted to your needs, and uses secondary research and analysis to drive initial conclusions, which are then tested/verified & enriched through high quality, high rapport and informed “dialogue” with carefully selected International Key Opinion Leaders.

Access to top International KOLs
​During the last 10 years alone, this has included in-depth discussions with over 700 physicians in both the US and Europe. We have access to top KOL's across multiple therapy areas in both territories, and are expert at identifying new influencers when required.
​
This primary and secondary insight is supplemented with significant operational marketing experience, plus the learnings from the governance and oversight of both risk-based and fee-based commercial partnerships, to provide a unique perspective for your project's needs.
​.

​
​What you get


​A high value product-oriented output, in line with your requirements, a live presentation to your team, plus ongoing advice & support, tailored to your project’s specific needs.
​
Scope chosen by you
This can include:​
• Review of the Disease/Condition
• Current management practice
• Current Clinical guidelines summary
• Patient Pathway and pressure points
• Product pipeline overview
• KOL Insights and Implications
• Key Opportunities identified
• Significant Barriers/Risks to entry
• Clinical Study Considerations
• Strategic Imperatives
• Commercial Critical Success Factors
 
Key to the value of the output is the identification of material “nuggets” of understanding gleaned during the process  which have the possibility to significantly impact the perceived potential for any product entering a market/sector.
​
​Therapy areas reviewed in recent years:
Diabetes, COPD, Asthma, Osteoporosis, Hyperlipidaemia, Multiple Sclerosis, Psoriasis, Heart Failure, Thrombolytics, Oncology (NSCLC, Breast Cancer, NHL, CLL, M. Myeloma, AML), Rheumatoid Arthritis, Inflammatory Bowel Disease, Alzheimer’s Disease, Dermatitis, Pseudobulbar Affect, Wound-care, ADHD, Haemophilia, Post Operative Pain, Allergy, Atherectomy, CMV Infection, Gout

Acuitas (n): Insight, Sharpness, Perception